A detailed history of Traverso Chambers Private Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Traverso Chambers Private Wealth Management, LLC holds 2,627 shares of AMGN stock, worth $873,503. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,627
Previous 2,675 1.79%
Holding current value
$873,503
Previous $718,000 5.29%
% of portfolio
0.18%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024

SELL
$255.7 - $288.46 $12,273 - $13,846
-48 Reduced 1.79%
2,627 $756,000
Q3 2023

Oct 26, 2023

BUY
$218.65 - $271.46 $18,803 - $23,345
86 Added 3.32%
2,675 $718,000
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $857 - $1,013
-4 Reduced 0.15%
2,589 $574,000
Q1 2023

Apr 12, 2023

BUY
$225.79 - $275.2 $18,966 - $23,116
84 Added 3.35%
2,593 $626,000
Q4 2022

Jan 27, 2023

SELL
$229.03 - $291.01 $5,725 - $7,275
-25 Reduced 0.99%
2,509 $658,000
Q3 2022

Oct 12, 2022

BUY
$224.46 - $253.15 $12,120 - $13,670
54 Added 2.18%
2,534 $571,000
Q2 2022

Jul 13, 2022

BUY
$230.71 - $256.74 $25,147 - $27,984
109 Added 4.6%
2,480 $603,000
Q1 2022

Apr 13, 2022

BUY
$219.27 - $242.57 $9,647 - $10,673
44 Added 1.89%
2,371 $573,000
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $23,268 - $26,629
117 Added 5.29%
2,327 $524,000
Q3 2021

Oct 08, 2021

BUY
$212.27 - $248.7 $12,099 - $14,175
57 Added 2.65%
2,210 $470,000
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $35,504 - $39,389
152 Added 7.6%
2,153 $525,000
Q1 2021

Apr 15, 2021

BUY
$221.91 - $258.6 $19,084 - $22,239
86 Added 4.49%
2,001 $498,000
Q4 2020

Jan 19, 2021

BUY
$216.38 - $257.67 $8,222 - $9,791
38 Added 2.02%
1,915 $440,000
Q3 2020

Oct 20, 2020

BUY
$234.65 - $260.95 $14,313 - $15,917
61 Added 3.36%
1,877 $477,000
Q2 2020

Jul 09, 2020

BUY
$197.81 - $242.74 $21,561 - $26,458
109 Added 6.39%
1,816 $428,000
Q1 2020

Apr 10, 2020

BUY
$182.24 - $241.7 $17,130 - $22,719
94 Added 5.83%
1,707 $346,000
Q4 2019

Jan 09, 2020

SELL
$189.21 - $243.2 $13,433 - $17,267
-71 Reduced 4.22%
1,613 $389,000
Q3 2019

Oct 31, 2019

BUY
$174.11 - $208.62 $1,218 - $1,460
7 Added 0.42%
1,684 $326,000
Q2 2019

Jul 17, 2019

SELL
$166.7 - $195.41 $6,001 - $7,034
-36 Reduced 2.1%
1,677 $313,000
Q1 2019

Apr 10, 2019

SELL
$180.87 - $203.88 $542 - $611
-3 Reduced 0.17%
1,713 $325,000
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $306,134 - $357,357
1,716 New
1,716 $334,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Traverso Chambers Private Wealth Management, LLC Portfolio

Follow Traverso Chambers Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traverso Chambers Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traverso Chambers Private Wealth Management, LLC with notifications on news.